Soluble TNFR1 Levels in Type 2 Diabetes and its Association with Stages of Proteinuria
Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this...
Saved in:
Published in | Journal of the Association of Physicians of India Vol. 71; no. 6; pp. 26 - 29 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
India
01.06.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0004-5772 |
DOI | 10.5005/japi-11001-0261 |
Cover
Abstract | Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy. Materials and methods: The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA). Results: Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)— 6.491, 95% confidence interval (CI)—1.868–22.55] and MAC (OR per standard deviation—15.28; 95% CI—3.76–62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC. Conclusion: Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians. |
---|---|
AbstractList | Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy.
The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA).
Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)- 6.491, 95% confidence interval (CI)-1.868-22.55] and MAC (OR per standard deviation-15.28; 95% CI-3.76-62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC.
Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians. Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy.AIMSEarly identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy.The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA).MATERIALS AND METHODSThe study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA).Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)- 6.491, 95% confidence interval (CI)-1.868-22.55] and MAC (OR per standard deviation-15.28; 95% CI-3.76-62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC.RESULTSSoluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)- 6.491, 95% confidence interval (CI)-1.868-22.55] and MAC (OR per standard deviation-15.28; 95% CI-3.76-62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC.Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians.CONCLUSIONSoluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians. Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of circulating soluble tumor necrosis factor receptor 1 (sTNFR1) in various stages of proteinuria (MAC) to determine the association of this marker with diabetic nephropathy. Materials and methods: The study was performed on 160 subjects, and a case-control methodology was employed. Type 2 diabetic subjects were recruited based on albuminuria and were grouped as (1) normoalbuminuria (NA); (2) microalbuminuria (MIC); (3) MAC; (4) normal glucose tolerance (NGT) subjects who served as healthy controls. sTNFR1 levels were measured by quantitative enzyme-linked immunosorbent assay (ELISA). Results: Soluble tumor necrosis factor receptor 1 (sTNFR1) levels were highest in the MAC group, followed by the microMAC group. The sTNFR1 levels were not statistically different between the NGT and NA groups. On regression models, sTNFR1 was associated with MIC [odds ratio (OR)— 6.491, 95% confidence interval (CI)—1.868–22.55] and MAC (OR per standard deviation—15.28; 95% CI—3.76–62.15; p < 0.001) even after controlling for all the possible confounding factors. Receiver operator curve (ROC) analysis revealed sTNFR1 cut-point of 1832 pg/mL had a C-statistic of 0.685 to discriminate MI from NA with 52% sensitivity. Whereas the sTNFR1 cut-point of 2050 pg/mL with a C-statistic of 0.8177 had 77% sensitivity for identifying MAC. Conclusion: Soluble tumor necrosis factor receptor 1 (sTNFR1) is significantly associated with MIC and MAC group in type 2 diabetes, and this suggests a potential early diagnostic biomarker role of sTNFR1 for MAC among Asian Indians. |
Author | Nilavan, Ezhil Lourdusamy, Raghul Gokulakrishnan, Kuppan Balaji, Nandagopal Srinivasan, Ramprasad |
Author_xml | – sequence: 1 givenname: Raghul surname: Lourdusamy fullname: Lourdusamy, Raghul – sequence: 2 givenname: Kuppan surname: Gokulakrishnan fullname: Gokulakrishnan, Kuppan – sequence: 3 givenname: Ezhil surname: Nilavan fullname: Nilavan, Ezhil – sequence: 4 givenname: Nandagopal surname: Balaji fullname: Balaji, Nandagopal – sequence: 5 givenname: Ramprasad surname: Srinivasan fullname: Srinivasan, Ramprasad |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37355839$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkDtPwzAUhT0U0QfMbMgjS-j1q4nHqlBAqgDRwho5yQ24SuMQJ1T996S0sDLd4XznXOkbkl7pSiTkgsG1AlDjtalswBgAC4BPWI8MAEAGKgx5nwy9XwMILQQ_JX0RCqUioQfkbemKNimQrh7nL4wu8AsLT21JV7sKKac31iTYoKemzKhtPJ1671JrGutKurXNB1025r3LXU6fa9egLdvamjNykpvC4_nxjsjr_HY1uw8WT3cPs-kiSDmELMA0UjxLmZYI0YSrnIVCcpQsNQKiZGKU1hGHRJsky_WEaZ6ISCaSZWHOZZiJEYHDbltWZrc1RRFXtd2YehcziPda4r2W-EdLvNfSVa4Olap2ny36Jt5Yn2JRmBJd62MecS0F5zrs0Msj2iYbzP6mf_V1wPgApLXzvsb83-_fp2Z9zA |
ContentType | Journal Article |
Copyright | Journal of the Association of Physicians of India 2011. |
Copyright_xml | – notice: Journal of the Association of Physicians of India 2011. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
DOI | 10.5005/japi-11001-0261 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 29 |
ExternalDocumentID | 10.5005/japi-11001-0261 37355839 10_5005_japi_11001_0261 |
Genre | Journal Article |
GroupedDBID | --- 29L 2WC 53G 5GY AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION DIK EBS EJD F5P GX1 OK1 OVT RNS TR2 XSB CGR CUY CVF ECM EIF NPM 7X8 ADTOC UNPAY |
ID | FETCH-LOGICAL-c2071-ec852dc194e08625f17342e41ca308b6a599820b9abdf96192b384b41d7f247d3 |
ISSN | 0004-5772 |
IngestDate | Tue Aug 19 22:14:37 EDT 2025 Thu Jul 10 19:30:09 EDT 2025 Wed Feb 19 02:24:02 EST 2025 Wed Oct 01 08:23:58 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | Journal of the Association of Physicians of India 2011. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2071-ec852dc194e08625f17342e41ca308b6a599820b9abdf96192b384b41d7f247d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.5005/japi-11001-0261 |
PMID | 37355839 |
PQID | 2829432297 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | unpaywall_primary_10_5005_japi_11001_0261 proquest_miscellaneous_2829432297 pubmed_primary_37355839 crossref_primary_10_5005_japi_11001_0261 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-06-01 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | India |
PublicationPlace_xml | – name: India |
PublicationTitle | Journal of the Association of Physicians of India |
PublicationTitleAlternate | J Assoc Physicians India |
PublicationYear | 2023 |
SSID | ssj0039332 |
Score | 2.327677 |
Snippet | Aims: Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels... Early identification of at-risk individuals for diabetic nephropathy would help in preventing or delaying end-stage renal failure. We measured the levels of... |
SourceID | unpaywall proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 26 |
SubjectTerms | Albuminuria - diagnosis Diabetes Mellitus, Type 2 - complications Diabetic Nephropathies - complications Humans Proteinuria - etiology Receptors, Tumor Necrosis Factor, Type I |
Title | Soluble TNFR1 Levels in Type 2 Diabetes and its Association with Stages of Proteinuria |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37355839 https://www.proquest.com/docview/2829432297 https://doi.org/10.5005/japi-11001-0261 |
UnpaywallVersion | publishedVersion |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals issn: 0004-5772 databaseCode: DIK dateStart: 20030101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: http://www.freemedicaljournals.com omitProxy: true ssIdentifier: ssj0039332 providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals issn: 0004-5772 databaseCode: GX1 dateStart: 20030101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php omitProxy: true ssIdentifier: ssj0039332 providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkGA8IO6Um4yEEAgZGtuJk0cu7SboCkIp6lvkXLxlK2mgjRDjz-MTO5eNSQxeoipS7Oo7n47POT4XhJ640suoEoKMqHIJz0RCpHAVianjCc8Vjgyg3nlv5u3O-fuFuxgMfvWrSzbxy-T4zLqS_5GqfqflClWy_yDZdlH9Qv_W8tVPLWH9PJeMIaYFlU_hbPLZeTGF_J86vTU0cdV3TVy1uSDoycIEYLWpuW-6zn6Cfg15UZms47Ps1boGpbcAfNSERdamIiXNWyU_1R-m1Vp-NUKU-wddBuLO6qhayiOYbW-nI3-oyrKj6SxfSns_NT4-6HJA3silPMztmZDCABcLkI1aUNZlV7WamBNXiBOaWDg9xvXVqtHHp7W9qzVIPWWgzAl0vnMIOJTdwdZc5s8-RpP5dBqF40X4tPxGYOQYXM3b-SsX0EUqPA_GX-ws2vwgFjBmWs3bP2r6QsGer07teNKk-cNPuYIuV0Upf_6Qy2XPdgmvoatWiPi1YdB1NMiKG-jSnk2ruIm-WCLhmkjYEAnnBQYiYYobImENO9ZEwj0eYCASNkTCK4V7RLqF5pNx-HaX2IEbJKHa1CRZ4rs0TZyAZ-DpusoRjNOMO4lkIz_2pKudczqKAxmnKgDXO2Y-j7mTCkW5SNlttFWsiuwuwirx_ECwTAXS5wmXQezFwkt5oqA9kM-H6FmDWVSaviqR9kcB3gjgjWp4I4B3iB43mEZa98GFliyyVbWOIAuA6xMpEEN0x4DdLsYEDA5gwRA9b9H_2073zrHTfbTd8fkB2tp8r7KH2i7dxI9q_vwGYImPNw |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Soluble+TNFR1+Levels+in+Type+2+Diabetes+and+its+Association+with+Stages+of+Proteinuria&rft.jtitle=Journal+of+the+Association+of+Physicians+of+India&rft.au=Lourdusamy%2C+Raghul&rft.au=Gokulakrishnan%2C+Kuppan&rft.au=Nilavan%2C+Ezhil&rft.au=Balaji%2C+Nandagopal&rft.date=2023-06-01&rft.issn=0004-5772&rft.volume=71&rft.issue=6&rft.spage=11&rft_id=info:doi/10.5005%2Fjapi-11001-0261&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-5772&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-5772&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-5772&client=summon |